AUSTIN FANN: Open Payments
NPI 1730943663 · DUNN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,255 in 55 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,176 · 2025 $1,255
Food & beverage: $1,255
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $313 |
| Novo Nordisk Inc | 12 | $242 |
| Amgen Inc. | 7 | $194 |
| Lilly USA, LLC | 6 | $187 |
| ABBVIE INC. | 5 | $122 |
| Otsuka America Pharmaceutical, Inc. | 5 | $89 |
| Currax Pharmaceuticals LLC | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Wegovy, AIRSUPRA, REPATHA, ZEPBOUND, VRAYLAR, BREZTRI, REXULTI, ONZETRA XSAIL.
Industry payments across NC — which companies pay providers there.
